PA1-41519
antibody from Invitrogen Antibodies
Targeting: RUNX2
AML3, CBFA1, CCD, CCD1, PEBP2A1, PEBP2aA1
Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [2]
- Other assay [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA1-41519 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- RUNX2 Polyclonal Antibody
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide
- Description
- PA1-41519 detects RUNX2 in chicken, chimpanzee, new world monkey, equine, human and mouse samples.
- Concentration
- 1.0 mg/mL
Submitted references Parathyroid Hormone Induces Human Valvular Endothelial Cells Dysfunction That Impacts the Osteogenic Phenotype of Valvular Interstitial Cells.
Nano-Polyplexes Mediated Transfection of Runx2-shRNA Mitigates the Osteodifferentiation of Human Valvular Interstitial Cells.
Curcumin eluting nanofibers augment osteogenesis toward phytochemical based bone tissue engineering.
Vadana M, Cecoltan S, Ciortan L, Macarie RD, Mihaila AC, Tucureanu MM, Gan AM, Simionescu M, Manduteanu I, Droc I, Butoi E
International journal of molecular sciences 2022 Mar 29;23(7)
International journal of molecular sciences 2022 Mar 29;23(7)
Nano-Polyplexes Mediated Transfection of Runx2-shRNA Mitigates the Osteodifferentiation of Human Valvular Interstitial Cells.
Voicu G, Rebleanu D, Constantinescu CA, Fuior EV, Ciortan L, Droc I, Uritu CM, Pinteala M, Manduteanu I, Simionescu M, Calin M
Pharmaceutics 2020 Jun 2;12(6)
Pharmaceutics 2020 Jun 2;12(6)
Curcumin eluting nanofibers augment osteogenesis toward phytochemical based bone tissue engineering.
Jain S, Krishna Meka SR, Chatterjee K
Biomedical materials (Bristol, England) 2016 Oct 6;11(5):055007
Biomedical materials (Bristol, England) 2016 Oct 6;11(5):055007
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of RUNX2 in Saos-2 cell lysate in the 1) absence and 2) presence of immunizing peptide using a RUNX2 polyclonal antibody (Product # PA1-41519) at 2 µg/mL.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of RUNX2 in Saos-2 cell lysate in the 1) absence and 2) presence of immunizing peptide. Samples were incubated in RUNX2 polyclonal antibody (Product # PA1-41519) using a dilution of 2 µg/mL.
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Protein expression of osteogenic molecules expressed by VEC exposed to PTH. ( A - E ) Quantification of protein expression of BMP-2, OPN, BSP, TGF-beta1 and Runx-2 in VEC as determined by western blot. ( F ) Representative western blot images for investigated molecules are presented. n = 3, * p < 0.05, ** p < 0.01 (control VEC vs. VEC exposed to PTH for 7 days); # p < 0.05, ### p < 0.001 (PTH+SB vs. PTH).